A detailed history of Russell Investments Group, Ltd. transactions in Axsome Therapeutics, Inc. stock. As of the latest transaction made, Russell Investments Group, Ltd. holds 1,015 shares of AXSM stock, worth $92,030. This represents 0.0% of its overall portfolio holdings.

Number of Shares
1,015
Previous 1,834 44.66%
Holding current value
$92,030
Previous $147,000 38.1%
% of portfolio
0.0%
Previous 0.0%

Shares

15 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 13, 2024

SELL
$78.93 - $95.84 $64,643 - $78,492
-819 Reduced 44.66%
1,015 $91,000
Q2 2024

Aug 08, 2024

BUY
$65.72 - $80.5 $68,545 - $83,961
1,043 Added 131.86%
1,834 $147,000
Q1 2024

May 08, 2024

BUY
$69.39 - $97.64 $53,916 - $75,866
777 Added 5550.0%
791 $63,000
Q4 2023

Feb 05, 2024

SELL
$57.42 - $83.61 $513,909 - $748,309
-8,950 Reduced 99.84%
14 $1,000
Q3 2023

Nov 13, 2023

SELL
$69.25 - $82.21 $1.08 Million - $1.29 Million
-15,635 Reduced 63.56%
8,964 $626,000
Q2 2023

Aug 10, 2023

BUY
$58.41 - $90.35 $1.44 Million - $2.22 Million
24,578 Added 117038.1%
24,599 $1.77 Million
Q1 2023

May 09, 2023

BUY
$58.39 - $75.0 $1,226 - $1,575
21 New
21 $1,000
Q4 2021

Jan 21, 2022

SELL
$30.7 - $43.36 $383,934 - $542,260
-12,506 Closed
0 $0
Q3 2021

Nov 08, 2021

SELL
$19.91 - $68.26 $48,082 - $164,847
-2,415 Reduced 16.19%
12,506 $411,000
Q2 2021

Aug 04, 2021

BUY
$50.63 - $73.5 $407,318 - $591,307
8,045 Added 117.0%
14,921 $1.01 Million
Q1 2021

May 10, 2021

BUY
$55.91 - $81.44 $40,590 - $59,125
726 Added 11.8%
6,876 $388,000
Q4 2020

Feb 08, 2021

SELL
$66.31 - $86.52 $135,869 - $177,279
-2,049 Reduced 24.99%
6,150 $500,000
Q3 2020

Nov 09, 2020

SELL
$68.34 - $85.84 $1.03 Million - $1.29 Million
-15,005 Reduced 64.67%
8,199 $583,000
Q2 2020

Aug 05, 2020

BUY
$49.87 - $98.69 $1.07 Million - $2.11 Million
21,415 Added 1197.04%
23,204 $1.9 Million
Q1 2020

May 06, 2020

BUY
$41.2 - $101.31 $73,706 - $181,243
1,789 New
1,789 $105,000

Others Institutions Holding AXSM

About Axsome Therapeutics, Inc.


  • Ticker AXSM
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 42,878,000
  • Market Cap $3.89B
  • Description
  • Axsome Therapeutics, Inc., a biopharmaceutical company, engages in the development of novel therapies for central nervous system (CNS) disorders in the United States. The company's product pipeline includes AXS-05, a therapeutic for the treatment of major depressive disorder and resistant depression disorders; and that is in the Phase III clinic...
More about AXSM
Track This Portfolio

Track Russell Investments Group, Ltd. Portfolio

Follow Russell Investments Group, Ltd. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Russell Investments Group, Ltd., based on Form 13F filings with the SEC.

News

Stay updated on Russell Investments Group, Ltd. with notifications on news.